Pen Needles Market Analysis And Forecast To 2031: By Type (Standard Pen Needles, Safety Pen Needles), Length (4mm, 5mm, 6mm, 8mm, 10mm, 12mm), Therapy (Insulin, GLP 1, Growth Hormone), And Region

Pen Needles Market Analysis And Forecast To 2031: By Type (Standard Pen Needles, Safety Pen Needles), Length (4mm, 5mm, 6mm, 8mm, 10mm, 12mm), Therapy (Insulin, GLP 1, Growth Hormone), And Region

The global pen needles market was valued at USD 1.2 billion in 2021 and it is anticipated to grow up to USD 5.2 billion by 2031, at a CAGR of 15.8% during the forecast period.


Pen needles use injection pens to deliver injectable medications into the body. These devices contain a hollow needle with a plastic hub attached to the injection pens, which are of varying lengths and diameter. Injection pen and pen needles are an alternative drug delivery method to the traditional vial/syringe method.

Market Trends and Drivers

Growing prevalence of chronic diseases will positively impact the market growth. The prevalence of chronic diseases has increased significantly in the last few years. Such diseases-including diabetes, osteoporosis, cardiovascular disease (CVD), and multiple sclerosis-require daily or weekly drug administration, typically using pen injectors. In the rapidly growing market, pen injectors have become the new standard for injectable drug delivery systems. Their popularity has soared due to their simplicity, reliability, and ability to be administered directly by the patient without the aid of a physician. The pen needle, a removable attachment, forms an integral part of the pen injector. The length of the needle and its sharpness is critical to ensure that the medication reaches the target tissues. Thus, the growing prevalence of chronic diseases has led to a greater focus on pen needle technologies to effectively handle the growing patient pool and increase patient compliance with therapies.

Market Restraints and Challenges

Preference for alternative modes of drug delivery may impede the market growth. While pen needles are an easy, hassle-free mode of drug delivery, they are also associated with needlestick injuries and infections, hyperglycemia, and pain. Insulin pen therapy is seen to cause hyperglycemia in some patients, as the dose cannot be regulated. Hence, in Europe, there has been a shift in diabetes treatment, from insulin pens to insulin pumps, due to their ability to perform automated insulin suspension and decrease the risk of hypoglycemia. This is a major factor restricting market growth. Although needle-free drug delivery technologies have addressed this issue to an extent, their range of applications in therapeutic areas is limited.

Global Pen Needles Market Segmental Overview

The report analyses the global pen needles market based on product, needle length, therapy, and region.

Global Pen Needles Market by Product

Based on product, it is segmented into standard pen needles and safety pen needles. Among these, the standard pen needles segment accounted for significant market share in 2021. The growth was attributed to the daily usage of these products for larger dosages by diabetic patients. People suffering from dexterity problems commonly use these needles. However, these needles are not preferred since there is a high risk of causing needlestick injuries, which hampers the safe applicability of pen needles. Hence, they are expected to have low demand in the near future. Standard pen needles are used more in home settings. Lack of proper training on the appropriate usage of these devices leads to improper doses and subsequent complications.

Global Pen Needles Market by Needle Length

Based on needle length, it is segmented into 4 mm, 5 mm, 6 mm, 8 mm, 10 mm and 12 mm. Among them, the 8 mm segment is expected to experience the fastest growth rate during the forecast period. These types of needles are most commonly prescribed to all patients including overweight patients suffering from the target disease. Safety, user convenience, and easy disposal are some of the features of 8mm needles, which lead to their preference in home settings. The easy availability and affordability are among the other factors expected to support the segment growth. Owing to their larger size, the needles are easy and safe to dispose of, with minimum chances of needlestick injury. Moreover, these are easy to separate from other sharp waste, and thus, are recommended.

Global Pen Needles Market by Therapy

Based on therapy, it is segmented into insulin, glucagon-like-peptide-1 (GLP-1), growth hormone. Among them, glucagon-like-peptide-1 (GLP-1) segment is expected to experience the fastest growth rate during the forecast period. This is due to its capability to minimize the blood glucose level among patients suffering from type 2 diabetes. GLP-1 therapy is looked at as a better alternative for insulin. Some of these drugs are generally taken on a weekly basis. This reduces the number of injections and increases patient convenience. Dulaglutide, Exenatide (extended-release), and Semaglutide are some of the GLP-1 drugs that are taken once weekly. Along with blood sugar control, these help with weight loss, which is of high importance in diabetes patients. Thus, aforementioned aspects will propel the segmental growth.

Geographical Analysis of Global Pen Needles Market

Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. Europe held the largest share in the market largely due to the on account of the rising prevalence of the target disease in this region. High patient volume and high product prices are the factors contributing to the large market share. Increasing patient awareness and favorable reimbursement scenarios across the region are aiding the adoption of advanced devices. A sedentary lifestyle and rising obesity rates in the region are also expected to fuel the demand. Moreover, the U.K. government is also taking initiatives to invest in diabetes care and research to improve treatment techniques for diabetic patients. Such factors will augment the regional market growth.

Major Players in the Global Pen Needles Market COVID-19 Impact

The impact of COVID-19 on the pen needles industry is observed to be positive. Type 2 diabetes, hypertension, and CVD significantly increase the risk for hospitalization and death in COVID-19 patients. Hence, managing these comorbidities has gained more focus for patients with existing conditions and those at the highest risk of contracting these conditions. This awareness has increased among healthcare professionals and patients and supported the growth of the management devices market. Hypoglycemia and hyperglycemia are both predictors for adverse outcomes in hospitalized patients. Optimized glycemic control should be pursued in patients with diabetes and SARS-CoV-2 infection to reduce the risk of severe COVID-19 course. Both insulin and GLP-1RAs have shown optimal glucose-lowering and anti-inflammatory effects in type 2 diabetic patients and may represent a valid therapeutic option to treat asymptomatic and non-critically ill COVID-19 diabetic patients. Customized therapies for diabetes treatment have become necessary for rigorous glucose monitoring and insulin or anti-diabetic drug dose adjustments. The adoption of insulin pens, insulin pumps, and continuous glucose monitoring devices has been increased for close monitoring and optimal management of diabetes. Pen needles are used in great quantities in diabetes management. So these would naturally be impacted by any change in overall product and service demand.

Recent Developments

• In May 2022, Roche Diabetes Care Launches ACCU-FINE Pen Needles for virtually painless insulin delivery.
• In February 2021, Ulticare safety pen needles are launched in two sizes, 5mm 30G and 8mm 30 G launched by UltiMed Inc. (US).
• In October 2020, Arkray Inc. (Japan) launched TechLITE Pen Needles which are now indicated for use with pen injector devices for the subcutaneous injection of drugs in the US.
• In January 2019, Becton, Dickinson and Company (US) launched Second Generation Standard Pen Needles.

Frequently Asked Questions

Q1. How big is the pen needles market market?Ans. The global pen needles market size was USD 1.2 billion in 2021 and is anticipated to reach USD 5.2 billion in 2031, growing at a rate of 15.8% from 2022 to 2031.
Q2. What is the pen needles market growth rate?Ans. The growth rate of the pen needles market is 15.8%.
Q3. Which region holds a major market share for the sepsis diagnostics market?Ans. North America holds a major market share of the pen needles market in 2021.
Q4. Which segment accounted for the largest pen needles market share?Ans. By therapy, the healthcare segment accounted for the largest pen needles market share.
Q5. Who are the key players in the sepsis diagnostics market?Ans. The global pen needles market report includes players such as
Q6. What are the factors driving the pen needles market growth?Ans. The major factors driving the growth of the market are the rising incidence of type 1 and type 2 diabetes across the globe.
Q7. What are the key growth strategies of pen needles market players?Ans. The key growth strategies of pen needles market players are product launch and product approval.
Q8. Which region will provide more business opportunities for the pen needles market during the forecast period?Ans. The Asia-Pacific region will provide more business opportunities for the pen needles market during the forecast period.

Please Note: This report will be delivered by publisher within 3-4 business days of order confirmation.